Sight Sciences, Inc. announced FDA 510(k) clearance of the TearCare System for the treatment of meibomian gland dysfunction. The TearCare System provides safe and effective localized heat therapy, in conjunction with manual gland expression, intended to help soften or liquify thickened meibum for effective gland clearance, the company says. FDA clearance is based on data from multiple studies of the TearCare System, including recent safety and effectiveness clinical data from the Olympia study published in Cornea. For additional information, visit www.sightsciences.com . OM